A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity-Reference-Cited by-同舟云学术

A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity

Published:2006-04 Issue:3 Volume:44 Page:198-211
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Müller Lutz,Mauthe Robert J.,Riley Christopher M.,Andino Marta M.,Antonis David De,Beels Chris,DeGeorge Joseph,De Knaep Alfons G.M.,Ellison Dean,Fagerland Jane A.,Frank Rebecca,Fritschel Betsy,Galloway Sheila,Harpur Ernie,Humfrey Charles D.N.,Jacks Alexander S.,Jagota Nirdosh,Mackinnon John,Mohan Ganapathy,Ness Daniel K.,O’Donovan Michael R.,Smith Mark D.,Vudathala Gopi,Yotti Larry

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference50 articles.

1. Comparative genotoxicity studies of ethyl carbamate and related chemicals: further support for vinyl carbamate as a proximate carcinogenic metabolite;Allen;Carcinogenesis,1982

2. Chemical structure, Salmonella mutagenicity extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the US NCI/NTP;Ashby;Mutation Research,1988

3. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP;Ashby;Mutation Research,1991

4. The influence of chemical structure on the extent and sites of carcinogenesis of 522 rodent carcinogens and 55 different human carcinogen exposures;Ashby;Mutation Research,1993

5. The use of structure-activity relationship analysis in the food contact notification program;Bailey;Regulatory Toxicology and Pharmacology,2005

Cited by 394 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical Strategy for Low-Level Estimation of Unstable Genotoxic Boronate Ester Impurities;Organic Process Research & Development;2024-04-30

2. Development of a fast RP-HPLC method for the separation of nifurtimox and its forced degradation products through a design of experiment approach;Journal of Molecular Liquids;2024-04

3. A Case to Support the Continued Use of Rifampin in Clinical Drug–Drug Interaction Studies;Clinical Pharmacology & Therapeutics;2024-03-18

4. Genotoxic Impurities in Critical Analysis of Product Development: Recent Advancements, Patents, and Current Challenges;Current Pharmaceutical Biotechnology;2024-03

5. Quantification of Structurally Alert Mutagenic Impurities in Meropenem Trihydrate Drug Substance by Liquid Chromatography with High Resolution Mass Spectrometer (LC-HRMS);American Journal of Analytical Chemistry;2024